Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Metformin Delayed-Release vs Immediate and Extended-Release in Healthy Subjects
NCT02291510Phase 1Completed
- Sponsor
- Elcelyx Therapeutics
- Start
- Oct 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of metformin delayed release in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Elcelyx Therapeutics. Primary endpoints: Area Under the Curve (0-t) of Plasma Metformin at 24 hours and Maximum Plasma Concentration of Metformin at 24 hours. Started Oct 2012; status: completed.
02
Drugs
metformin delayed release
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02291510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291510.